BPC
UTHR icon

Banque Pictet & Cie’s United Therapeutics UTHR Stock Holding History

Banque Pictet & Cie’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.66M Buy
4,914
+383
+8% +$216K 0.02% 178
2026
Q1 		$2.69M Sell
4,531
-97
-2% -$48.3K 0.02% 195
2025
Q4 		$2.25M Sell
4,628
-150
-3% -$69.9K 0.01% 204
2025
Q3 		$2M Buy
+4,778
New +$1.61M 0.01% 218

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Banque Pictet & Cie's UTHR Position: Q2 2026 in Review

Banque Pictet & Cie increased its United Therapeutics (UTHR) stake by 8.5% in Q2 2026, buying an estimated $216K and bringing the position to 4,914 shares worth $2.66M. The position accounts for 0.02% of the portfolio, ranked #178.

Banque Pictet & Cie first reported a position in UTHR in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.69M in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Banque Pictet & Cie held 4,914 shares of United Therapeutics worth $2.66M as of Q2 2026.
  • Banque Pictet & Cie bought 383 United Therapeutics shares in Q2 2026, an estimated $216K.
  • United Therapeutics made up 0.02% of Banque Pictet & Cie's portfolio in Q2 2026, its #178 holding.
  • Banque Pictet & Cie first reported a position in United Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Banque Pictet & Cie's United Therapeutics position peaked at $2.69M in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.